pluri.jpg
Pluri’s PLX-R18 Increases Blood Cell Counts and Reduces Need for Transfusions in a Phase I Study: Results Published in Nature Bone Marrow Transplantation
August 16, 2023 07:00 ET | Pluri Inc.
Results support the development of PLX-R18 for hematologic acute radiation syndrome (H-ARS), currently under a $4.2 million contract with the U.S. National Institutes of HealthPLX-R18 has the...
Aptose Biosciences Inc. logo
Aptose Reports Results for the Second Quarter 2023
August 10, 2023 16:02 ET | Aptose Biosciences, Inc.
            ─ CRc Response Rate 50% with Tuspetinib/Venetoclax Doublet in Evaluable Patients ─ ─ CRc 44% in Patients Who Failed Prior Venetoclax ── CRc 43% in Patients with Wildtype FLT3 ── CRc 67%...
Research Nester Logo.jpg
Plasma Fractionation Market revenue to exceed USD 37 Billion by 2033, says Research Nester
July 31, 2023 06:00 ET | Research Nester
New York, July 31, 2023 (GLOBE NEWSWIRE) -- The global plasma fractionation market size is slated to expand at ~7% CAGR between 2023 and 2033. The market is poised to garner a revenue of USD 37...
THC_ONCIconsWinners_Ad_0713_1920x1080
Targeted Oncology™ announces recipients of its Q2 Oncology Icons award program
July 18, 2023 10:44 ET | Targeted Oncology™
CRANBURY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of...
TIP_link_300x300.jpg
$2.68Bn Growth for Companion Animal Diagnostics Market to Hit 4.1% CAGR, Globally, by 2027 with Clinical Biochemistry Segment Driving Growth during 2020-2027 | The Insight Partners
July 11, 2023 09:26 ET | The Insight Partners
Pune, India, July 11, 2023 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Companion Animal Diagnostics Market Size Report, Share, Revenue, Growth Strategy, Industry...
BTG Pharmaceuticals
BTG Pharmaceuticals Statement on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommendation for Use of Glucarpidase (Voraxaze®) and MTXPK.org
June 22, 2023 08:28 ET | BTG Specialty Pharmaceuticals
West Conshohocken, PA, June 22, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, highlights the recent updates to the National Comprehensive Cancer Network (NCCN) Guidelines for Acute...
GMILogo_Vertical-Gradient.png
Veterinary Point of Care Diagnostics Market to cross USD 4 billion by 2032, says Global Market Insights Inc.
June 19, 2023 19:00 ET | Global Market Insights Inc.
Selbyville, Delaware, June 19, 2023 (GLOBE NEWSWIRE) -- Veterinary Point of Care Diagnostics Market size will surpass USD 4 billion by 2032, due to the rising prevalence of infectious diseases in...
PRPO logo.png
Precipio’s Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy
June 14, 2023 09:49 ET | Precipio, Inc.
NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen Cytopenia panel as part of the diagnostic process for...
new_logo.png
Veterinary Reference Laboratory Market to surpass USD 12 billion by 2032, Says Graphical Research Powered by GMI
June 12, 2023 21:00 ET | Graphical Research
Selbyville, Delaware, June 12, 2023 (GLOBE NEWSWIRE) -- Veterinary Reference Laboratory Market size will cross USD 12 billion by 2032. Increasing public-private investments in animal healthcare...
Aptose Biosciences Inc. logo
Aptose Presents Highlights from Clinical Update
June 10, 2023 12:00 ET | Aptose Biosciences, Inc.
Finalized Dose Escalation/Dose Exploration Trial in 77 R/R AML PatientsFavorable safety with monotherapy responses across four dose levels with no DLT in mutationally diverse and difficult to treat...